Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modeling Ketosis-Prone Diabetes Remission
NCT06699810Phase 4Recruiting
- Sponsor
- Emory University
- Start
- Jan 2025
- Primary completion
- Jan 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by Emory University. Primary endpoints: Quantify Changes in Blood Glucose at 3 months and Development of Mathematical Models at 3 months. Started Jan 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06699810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06699810.